May 17, 2013
Toyama Chemical, a subsidiary of Fujifilm Holdings, announced on May 14 that it signed a license agreement with US-based Cempra to exclusively develop and commercialize the novel macrolide agent solithromycin, which was discovered by Cempra, in Japan. Toyama will initiate...read more